A short summary of the news story in Dagens Næringsliv (Norwegian only):
Given the uncertainty of the USA's commitment in a future pandemic, Norway must prioritize its own vaccine production. The emergence of new, deadly diseases is inevitable, and relying on external help is risky. Key Reasons:
- EU Collaboration: Norway can become a valuable contributor to the EU's health preparedness.
- US Vaccine Production: American producers might prioritize other countries over Norway in a crisis.
- Technological and Economic Potential: Norway has the resources and expertise to develop and produce vaccines domestically.
Vaccines are crucial for combating serious diseases. Norway currently has no domestic production of human vaccines, but establishing a commercial industry for vaccines and advanced medicines would ensure preparedness for future pandemics.